+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Personalized Cell & Gene Therapies Market - Global Forecast 2025-2030- Product Image
Personalized Cell & Gene Therapies Market - Global Forecast 2025-2030- Product Image
Sale

Personalized Cell & Gene Therapies Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 193 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6055132
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Personalized Cell & Gene Therapies Market is undergoing rapid transformation as the convergence of biotechnology innovation and patient-centered medicine drives the sector forward. This executive summary distills the insights needed for senior decision-makers to navigate an evolving landscape and identify strategic opportunities in next-generation personalized therapeutic development.

Market Snapshot: Personalized Cell & Gene Therapies Market Growth and Outlook

The Personalized Cell & Gene Therapies Market grew from USD 13.88 billion in 2024 to USD 16.30 billion in 2025 and is projected to expand at a CAGR of 20.01%, reaching USD 41.49 billion by 2030. Surging demand for advanced targeted treatments, robust clinical pipelines, and investment in scalable biomanufacturing are fueling this expansion. Strong adoption across oncology, rare diseases, and complex conditions is enhancing the sector's accessibility and relevance for diverse patient populations and stakeholders.

Scope & Segmentation: Comprehensive Coverage Across Technologies, Patient Groups, and Geographies

  • Therapy Types: Cell therapy and gene therapy modalities, each with unique developmental trajectories and clinical focuses.
  • Patient Types: Targeting adults, geriatrics, and pediatric groups, addressing a spectrum from oncology and degenerative disorders to pediatric genetic diseases.
  • Therapeutic Areas: Coverage includes cardiology, hematology, immunology, metabolic diseases, neurology, oncology, and rare diseases.
  • End Users: Biopharmaceutical companies, hospitals and clinics, and research institutions form the core user base driving R&D and clinical deployment.
  • Geographic Regions: Americas (including key US states, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (with major and emerging markets), and Asia-Pacific (featuring high-growth economies and established regulatory hubs).
  • Key Technologies: Latest gene editing methods such as CRISPR and base editing, advanced vector engineering, automated manufacturing, and digital patient engagement platforms support innovation cycles.
  • Leading Companies: Profiles feature Adaptimmune Limited, Allogene Therapeutics, Amgen Inc., Arcellx, Inc., Beam Therapeutics Inc., BioCell Innovations, bluebird bio, Inc., Bristol-Myers Squibb Company, Caribou Biosciences, Inc., Celyad Oncology SA, CRISPR Therapeutics AG, Editas Medicine, Inc., Fate Therapeutics, Inc., Genentech, Inc., Gilead Sciences, Inc., Intellia Therapeutics, Inc., Lonza Group Ltd., Miltenyi Biomedicine GmbH, Novartis AG, Sana Biotechnology, Inc., Sangamo Therapeutics, Inc., and Sarepta Therapeutics, Inc.

Key Takeaways for Senior Decision-Makers

  • Technological breakthroughs in genome editing, vector engineering, and cell manufacturing are accelerating the shift from generalized to highly personalized therapies.
  • Collaborative ecosystems—including public-private partnerships and alliances across academic, industrial, and regulatory stakeholders—are dissolving silos and creating agile value chains delivering faster translational progress.
  • Differentiated strategies are required for patient subsets, as adult and geriatric populations drive volume, while pediatric indications highlight the need for specialized protocols.
  • Oncology anchors commercial momentum, but neurology, immunology, and rare diseases are emerging as strong innovation verticals demanding tailored vectors and cell products.
  • End user variety shapes adoption and success, with biopharma leading scalable development, hospitals driving clinical administration, and research institutions serving as hubs for discovery and technology transfer.

Tariff Impact: Navigating Trade Changes and Supply Chain Disruption

Revised United States tariffs for 2025 introduce cost and sourcing challenges for raw materials, reagents, and specialized equipment vital to therapy production. Amid increased duties, organizations are restructuring supply chains, pursuing nearshoring, qualifying alternative suppliers, and targeting in-house production to sustain supply reliability. This climate may incentivize domestic infrastructure investment and foster new regional manufacturing clusters, but supply chain agility and policy engagement remain central to risk mitigation.

Methodology & Data Sources

This report draws from scientific literature, clinical trial registries, regulatory documents, and industry analysis. Primary interviews with sector leaders and subject matter experts add qualitative context, and findings are validated via peer review and ethical research protocols to ensure actionable, reliable market insights.

Why This Report Matters to Your Business

  • Enables strategic planning by illuminating critical trends in technology, market segmentation, and regulatory influence across global regions.
  • Equips key decision-makers with actionable guidance to optimize manufacturing, supply chain resilience, and stakeholder collaboration for competitive advantage.
  • Offers detailed competitive benchmarking to support investment prioritization and partnership selection aligned with evolving market dynamics.

Conclusion

The Personalized Cell & Gene Therapies Market presents significant growth potential, supported by scientific advancement and multi-stakeholder engagement. Organizations that integrate innovation, regulatory strategy, and operational excellence will advance patient outcomes and secure long-term value.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Regulatory frameworks evolving to accelerate approval of personalized cell and gene therapies
5.2. Emergence of allogeneic CAR-T platforms reducing manufacturing time and cost barriers
5.3. Integration of AI-driven bioinformatics to optimize vector design and patient stratification
5.4. Clinical validation of in vivo gene editing approaches targeting mitochondrial DNA disorders
5.5. Expansion of next-generation manufacturing facilities to meet rising personalized therapy demand
5.6. Development of universal donor cell banks to streamline treatment availability and equity
5.7. Adoption of digital twin models to predict personalized therapy responses and safety outcomes
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Personalized Cell & Gene Therapies Market, by Therapy Type
8.1. Introduction
8.2. Cell Therapy
8.3. Gene Therapy
9. Personalized Cell & Gene Therapies Market, by Patient Type
9.1. Introduction
9.2. Adult
9.3. Geriatric
9.4. Pediatric
10. Personalized Cell & Gene Therapies Market, by Therapeutic Area
10.1. Introduction
10.2. Cardiology
10.3. Hematology
10.4. Immunology
10.5. Metabolic Diseases
10.6. Neurology
10.7. Oncology
10.8. Rare Diseases
11. Personalized Cell & Gene Therapies Market, by End User
11.1. Introduction
11.2. Biopharmaceutical Companies
11.3. Hospitals & Clinics
11.4. Research Institutions
12. Americas Personalized Cell & Gene Therapies Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Personalized Cell & Gene Therapies Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Personalized Cell & Gene Therapies Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Adaptimmune Limited
15.3.2. Allogene Therapeutics
15.3.3. Amgen Inc.
15.3.4. Arcellx, Inc.
15.3.5. Beam Therapeutics Inc.
15.3.6. BioCell Innovations
15.3.7. bluebird bio, Inc.
15.3.8. Bristol-Myers Squibb Company
15.3.9. Caribou Biosciences, Inc.
15.3.10. Celyad Oncology SA
15.3.11. CRISPR Therapeutics AG
15.3.12. Editas Medicine, Inc.
15.3.13. Fate Therapeutics, Inc.
15.3.14. Genentech, Inc.
15.3.15. Gilead Sciences, Inc.
15.3.16. Intellia Therapeutics, Inc.
15.3.17. Lonza Group Ltd.
15.3.18. Miltenyi Biomedicine GmbH
15.3.19. Novartis AG
15.3.20. Sana Biotechnology, Inc.
15.3.21. Sangamo Therapeutics, Inc.
15.3.22. Sarepta Therapeutics, Inc
16. ResearchAI17. ResearchStatistics18. ResearchContacts19. ResearchArticles20. Appendix
List of Figures
FIGURE 1. PERSONALIZED CELL & GENE THERAPIES MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY PATIENT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY PATIENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2030 (%)
FIGURE 10. GLOBAL PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. PERSONALIZED CELL & GENE THERAPIES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. PERSONALIZED CELL & GENE THERAPIES MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. PERSONALIZED CELL & GENE THERAPIES MARKET: RESEARCHAI
FIGURE 24. PERSONALIZED CELL & GENE THERAPIES MARKET: RESEARCHSTATISTICS
FIGURE 25. PERSONALIZED CELL & GENE THERAPIES MARKET: RESEARCHCONTACTS
FIGURE 26. PERSONALIZED CELL & GENE THERAPIES MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. PERSONALIZED CELL & GENE THERAPIES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY CELL THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY CELL THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY GENE THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY GENE THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY ADULT, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY ADULT, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY GERIATRIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY PEDIATRIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY CARDIOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY HEMATOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY HEMATOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY METABOLIC DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY METABOLIC DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY NEUROLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY RARE DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY RARE DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. AMERICAS PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 48. AMERICAS PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 49. AMERICAS PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 50. AMERICAS PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 51. AMERICAS PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 52. AMERICAS PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 53. AMERICAS PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 54. AMERICAS PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 55. AMERICAS PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 56. AMERICAS PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 57. UNITED STATES PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 58. UNITED STATES PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 59. UNITED STATES PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 60. UNITED STATES PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 61. UNITED STATES PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 62. UNITED STATES PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 63. UNITED STATES PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 64. UNITED STATES PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 65. UNITED STATES PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 66. UNITED STATES PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 67. CANADA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 68. CANADA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 69. CANADA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 70. CANADA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 71. CANADA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 72. CANADA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 73. CANADA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 74. CANADA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 75. MEXICO PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 76. MEXICO PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 77. MEXICO PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 78. MEXICO PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 79. MEXICO PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 80. MEXICO PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 81. MEXICO PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 82. MEXICO PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 83. BRAZIL PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 84. BRAZIL PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 85. BRAZIL PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 86. BRAZIL PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 87. BRAZIL PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 88. BRAZIL PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 89. BRAZIL PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 90. BRAZIL PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 91. ARGENTINA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 92. ARGENTINA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 93. ARGENTINA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 94. ARGENTINA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 95. ARGENTINA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 96. ARGENTINA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 97. ARGENTINA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 98. ARGENTINA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 109. UNITED KINGDOM PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 110. UNITED KINGDOM PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 111. UNITED KINGDOM PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 112. UNITED KINGDOM PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 113. UNITED KINGDOM PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 114. UNITED KINGDOM PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 115. UNITED KINGDOM PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 116. UNITED KINGDOM PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 117. GERMANY PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 118. GERMANY PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 119. GERMANY PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 120. GERMANY PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 121. GERMANY PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 122. GERMANY PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 123. GERMANY PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 124. GERMANY PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 125. FRANCE PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 126. FRANCE PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 127. FRANCE PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 128. FRANCE PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 129. FRANCE PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 130. FRANCE PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 131. FRANCE PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 132. FRANCE PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 133. RUSSIA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 134. RUSSIA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 135. RUSSIA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 136. RUSSIA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 137. RUSSIA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 138. RUSSIA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 139. RUSSIA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 140. RUSSIA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 141. ITALY PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 142. ITALY PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 143. ITALY PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 144. ITALY PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 145. ITALY PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 146. ITALY PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 147. ITALY PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 148. ITALY PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 149. SPAIN PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 150. SPAIN PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 151. SPAIN PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 152. SPAIN PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 153. SPAIN PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 154. SPAIN PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 155. SPAIN PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 156. SPAIN PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 157. UNITED ARAB EMIRATES PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 158. UNITED ARAB EMIRATES PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 159. UNITED ARAB EMIRATES PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 160. UNITED ARAB EMIRATES PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 161. UNITED ARAB EMIRATES PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 162. UNITED ARAB EMIRATES PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 163. UNITED ARAB EMIRATES PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 164. UNITED ARAB EMIRATES PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 165. SAUDI ARABIA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 166. SAUDI ARABIA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 167. SAUDI ARABIA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 168. SAUDI ARABIA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 169. SAUDI ARABIA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 170. SAUDI ARABIA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 171. SAUDI ARABIA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 172. SAUDI ARABIA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 173. SOUTH AFRICA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 174. SOUTH AFRICA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 175. SOUTH AFRICA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 176. SOUTH AFRICA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 177. SOUTH AFRICA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 178. SOUTH AFRICA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 179. SOUTH AFRICA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 180. SOUTH AFRICA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 181. DENMARK PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 182. DENMARK PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 183. DENMARK PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 184. DENMARK PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 185. DENMARK PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 186. DENMARK PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 187. DENMARK PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 188. DENMARK PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 189. NETHERLANDS PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 190. NETHERLANDS PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 191. NETHERLANDS PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 192. NETHERLANDS PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 193. NETHERLANDS PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 194. NETHERLANDS PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 195. NETHERLANDS PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 196. NETHERLANDS PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 197. QATAR PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 198. QATAR PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 199. QATAR PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 200. QATAR PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 201. QATAR PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 202. QATAR PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 203. QATAR PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 204. QATAR PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 205. FINLAND PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 206. FINLAND PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 207. FINLAND PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 208. FINLAND PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 209. FINLAND PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 210. FINLAND PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 211. FINLAND PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 212. FINLAND PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 213. SWEDEN PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 214. SWEDEN PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 215. SWEDEN PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 216. SWEDEN PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 217. SWEDEN PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 218. SWEDEN PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 219. SWEDEN PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 220. SWEDEN PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 221. NIGERIA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 222. NIGERIA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 223. NIGERIA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 224. NIGERIA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 225. NIGERIA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 226. NIGERIA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 227. NIGERIA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 228. NIGERIA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 229. EGYPT PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 230. EGYPT PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 231. EGYPT PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 232. EGYPT PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 233. EGYPT PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 234. EGYPT PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 235. EGYPT PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 236. EGYPT PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 237. TURKEY PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 238. TURKEY PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 239. TURKEY PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 240. TURKEY PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 241. TURKEY PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 242. TURKEY PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 243. TURKEY PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 244. TURKEY PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 245. ISRAEL PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 246. ISRAEL PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 247. ISRAEL PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 248. ISRAEL PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 249. ISRAEL PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 250. ISRAEL PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 251. ISRAEL PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 252. ISRAEL PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 253. NORWAY PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 254. NORWAY PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 255. NORWAY PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 256. NORWAY PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 257. NORWAY PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 258. NORWAY PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 259. NORWAY PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 260. NORWAY PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 261. POLAND PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 262. POLAND PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 263. POLAND PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 264. POLAND PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 265. POLAND PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 266. POLAND PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 267. POLAND PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 268. POLAND PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 269. SWITZERLAND PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 270. SWITZERLAND PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 271. SWITZERLAND PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 272. SWITZERLAND PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 273. SWITZERLAND PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 274. SWITZERLAND PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 275. SWITZERLAND PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 276. SWITZERLAND PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 277. ASIA-PACIFIC PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 278. ASIA-PACIFIC PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 279. ASIA-PACIFIC PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 280. ASIA-PACIFIC PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 281. ASIA-PACIFIC PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 282. ASIA-PACIFIC PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 283. ASIA-PACIFIC PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 284. ASIA-PACIFIC PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 285. ASIA-PACIFIC PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 286. ASIA-PACIFIC PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 287. CHINA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 288. CHINA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 289. CHINA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 290. CHINA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 291. CHINA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 292. CHINA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 293. CHINA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 294. CHINA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 295. INDIA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 296. INDIA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 297. INDIA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 298. INDIA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 299. INDIA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPEUTIC

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Personalized Cell & Gene Therapies market report include:
  • Adaptimmune Limited
  • Allogene Therapeutics
  • Amgen Inc.
  • Arcellx, Inc.
  • Beam Therapeutics Inc.
  • BioCell Innovations
  • bluebird bio, Inc.
  • Bristol-Myers Squibb Company
  • Caribou Biosciences, Inc.
  • Celyad Oncology SA
  • CRISPR Therapeutics AG
  • Editas Medicine, Inc.
  • Fate Therapeutics, Inc.
  • Genentech, Inc.
  • Gilead Sciences, Inc.
  • Intellia Therapeutics, Inc.
  • Lonza Group Ltd.
  • Miltenyi Biomedicine GmbH
  • Novartis AG
  • Sana Biotechnology, Inc.
  • Sangamo Therapeutics, Inc.
  • Sarepta Therapeutics, Inc

Table Information

Report AttributeDetails
No. of Pages193
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 16.3 billion
Forecasted Market Value ( USD ) by 2030 $ 41.49 billion
Compound Annual Growth Rate20.0%
Regions CoveredGlobal
No. of Companies Mentioned23

Related Topics

Related Reports

Personalized Nanotechnology for Cell & Gene Therapies Market - Global Forecast 2025-2030 - Product Image

Personalized Nanotechnology for Cell & Gene Therapies Market - Global Forecast 2025-2030

  • Report
  • 199 Pages
  • Global
From
Cell & Gene Therapy Market - Global Forecast 2025-2030 - Product Image

Cell & Gene Therapy Market - Global Forecast 2025-2030

  • Report
  • 183 Pages
  • Global
From
Cell Sheet-based Gene Therapy Market - A Global and Regional Analysis: Focus on Technology Type, Cell-sheet Type, Source Type, Application Type, End User, and Regional Analysis - Analysis and Forecast, 2025-2035 - Product Image

Cell Sheet-based Gene Therapy Market - A Global and Regional Analysis: Focus on Technology Type, Cell-sheet Type, Source Type, Application Type, End User, and Regional Analysis - Analysis and Forecast, 2025-2035

  • Report
  • 128 Pages
  • Global
From
Cell and Gene Therapy Third-Party Logistics Market Size, Share & Trends Analysis Report by Type (Clinical), Product (Cell Therapies, Gene Therapies), Temperature Range (Ambient Storage), Therapeutic Area, End-use, Region, with Growth Forecasts, 2025-2030 - Product Image

Cell and Gene Therapy Third-Party Logistics Market Size, Share & Trends Analysis Report by Type (Clinical), Product (Cell Therapies, Gene Therapies), Temperature Range (Ambient Storage), Therapeutic Area, End-use, Region, with Growth Forecasts, 2025-2030

  • Report
  • 150 Pages
  • Global
From
Gene Therapy Market Outlook to 2029 - Product Image

Gene Therapy Market Outlook to 2029

  • Report
  • 83 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.